Figure 6: Patient-derived xenografts with high expression of BRD4-L and BRD4-S are resistant to cisplatin/paclitaxel chemotherapy.
Credit
2023 Drumond-Bock et al.
Usage Restrictions
Original Content
License
Original content
Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.